HOTH Q4 2019 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$309

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-10.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$3M

Total Liabilities

$440,121

Stockholders' Equity

$2M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$309	-$28,252	+98.9%
Operating Income	-$4M	-$624,044	-527.8%
Net Income	-$4M	-$480,044	-714.9%